Calidi Biotherapeutics CLDI
NYSE CLDI
$0.64 -0.13 (-16.52%)
As of: Oct 22, 2026 · 3:57 PM EDT

Calidi Biotherapeutics (CLDI) Ending Cash Balance (2021 - 2023)

Updated

Analysis

Calidi Biotherapeutics (CLDI) Ending Cash Balance (2021 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 6.57 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 4.88 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.03 Bn
10 Calidi Biotherapeutics 907,797.59 -24.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 669,867.00
Mar 31, 2023 82,828.00
Dec 31, 2022 93,892.00
Sep 30, 2022 39,944.00
Jun 30, 2022 328,843.00
Mar 31, 2022 597,522.00
Dec 31, 2021 1.06 Mn
API Access

Calidi Biotherapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=CLDI&period=max&api_key=YOUR_API_KEY